³Ô¹ÏºÚÁÏ

Search or filter publications

Search publications Search

Filter by type:

Filter by publication type

• Book
• Book chapter
• Conference paper
• Journal article
• Patent
• Report
• Software

Filter by year:

Filter from 201720162015201420132012 to Filter to 201720162015201420132012

---

Search results

• Journal article
  Yamaguchi Y, Harker JA, Wang B, Openshaw PJ, Tregoning JS, Culley FJet al., 2012,
  , JOURNAL OF VIROLOGY, Vol: 86, Pages: 10456-10461, ISSN: 0022-538X
  • Cite
  • Citations: 30
• Journal article
  Pattani A, McKay PF, Garland MJ, Curran RM, Migalska K, Cassidy CM, Malcolm RK, Shattock RJ, McCarthy HO, Donnelly RFet al., 2012,
  , JOURNAL OF CONTROLLED RELEASE, Vol: 162, Pages: 529-537, ISSN: 0168-3659
  • Cite
  • Citations: 79
• Conference paper
  Mann JF, McKay PF, Swales J, Klein K, Fiserova A, Cope A, Shattock RJet al., 2012,
  , Publisher: BIOMED CENTRAL LTD, ISSN: 1742-4690
  • Cite
• Conference paper
  McKay PF, Cope AV, Swales J, Joseph S, Esteban M, Tatoud R, Carter D, Weber J, Shattock RJet al., 2012,
  , Publisher: BIOMED CENTRAL LTD, ISSN: 1742-4690
  • Cite
• Conference paper
  McKay PF, Mann JF, Pattani A, Kett VL, Malcolm K, Shattock RJet al., 2012,
  , Publisher: BIOMED CENTRAL LTD, ISSN: 1742-4690
  • Cite
  • Citations: 3
• Journal article
  Du T, Hu K, Yang J, Jin J, Li C, Stieh D, Griffin GE, Shattock RJ, Hu Qet al., 2012,
  , ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Vol: 56, Pages: 4640-4649, ISSN: 0066-4804
  • Cite
  • Citations: 21
• Journal article
  Stefanidou M, Herrera C, Armanasco N, Shattock RJet al., 2012,
  , ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Vol: 56, Pages: 4381-4390, ISSN: 0066-4804
  • Cite
  • Citations: 30
• Journal article
  Arias MA, Van Roey GA, Tregoning JS, Moutaftsi M, Coler RN, Windish HP, Reed SG, Carter D, Shattock RJet al., 2012,
  , PLOS One, Vol: 7, ISSN: 1932-6203

  Successful vaccine development against HIV will likely require the induction of strong, long-lasting humoral and cellularimmune responses in both the systemic and mucosal compartments. Based on the known immunological linkage betweenthe upper-respiratory and urogenital tracts, we explored the potential of nasal adjuvants to boost immunization for theinduction of vaginal and systemic immune responses to gp140. Mice were immunized intranasally with HIV gp140 togetherwith micellar and emulsion formulations of a synthetic TLR4 agonist, Glucopyranosyl Lipid Adjuvant (GLA) and responseswere compared to R848, a TLR7/8 agonist, or chitosan, a non TLR adjuvant. GLA and chitosan but not R848 greatlyenhanced serum immunoglobulin levels when compared to antigen alone. Both GLA and chitosan induced high IgG andIgA titers in nasal and vaginal lavage and feces. The high IgA and IgG titers in vaginal lavage were associated with highnumbers of gp140-specific antibody secreting cells in the genital tract. Whilst both GLA and chitosan induced T cellresponses to immunization, GLA induced a stronger Th17 response and chitosan induced a more Th2 skewed response. Ourresults show that GLA is a highly potent intranasal adjuvant greatly enhancing humoral and cellular immune responses,both systemically and mucosally.

  • Abstract
  • Cite
• Journal article
  Ruffin N, Borggren M, Euler Z, Fiorino F, Grupping K, Hallengard D, Javed A, Mendonca K, Pollard C, Reinhart D, Saba E, Sheik-Khalil E, Skold A, Ziglio S, Scarlatti G, Gotch F, Wahren B, Shattock RJet al., 2012,
  , JOURNAL OF TRANSLATIONAL MEDICINE, Vol: 10, ISSN: 1479-5876
  • Cite
  • Citations: 6
• Journal article
  Huang W, Hu K, Luo S, Zhang M, Li C, Jin W, Liu Y, Griffin GE, Shattock RJ, Hu Qet al., 2012,
  , JOURNAL OF IMMUNOLOGY, Vol: 188, Pages: 6247-6257, ISSN: 0022-1767
  • Cite
  • Citations: 51

This data is extracted from the Web of Science and reproduced under a licence from Thomson Reuters. You may not copy or re-distribute this data in whole or in part without the written consent of the Science business of Thomson Reuters.